Edition:
United Kingdom

Koninklijke DSM NV (DSMN.AS)

DSMN.AS on Amsterdam Stock Exchange

84.14EUR
4:35pm GMT
Change (% chg)

€0.44 (+0.53%)
Prev Close
€83.70
Open
€83.88
Day's High
€84.84
Day's Low
€83.66
Volume
772,740
Avg. Vol
731,871
52-wk High
€86.70
52-wk Low
€60.75

Select another date:

Wed, Feb 14 2018

UPDATE 1-Dutch chemical firm DSM's Q4 profit beats expectations

AMSTERDAM, Feb 14 Dutch speciality chemicals company DSM on Wednesday reported a higher-than-expected 14 percent rise in fourth-quarter core profit, to 359 million euros ($444.3 million), as sales of its food ingredients and basic materials continued to grow.

Dutch chemical firm DSM's Q4 profit beats expectations

AMSTERDAM, Feb 14 Dutch speciality chemicals company DSM on Wednesday reported a higher-than-expected 14 percent rise in fourth-quarter core profit, to 359 million euros ($444.3 million), as sales of its food ingredients and basic materials continued to grow.

BRIEF-DSM Announces DSM-Niaga Research Collaboration With Ecor

* PRELIMINARY RESULTS LED TO FURTHER INVESTIGATING OF APPLICATIONS AND WILL LEAD TO NEW FULLY RECYCLABLE PRODUCTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-DSM acquires Brazilian production facility from Amyris

* DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris

BRIEF-DSM signs technology partnership agreement with Toyota Motorsport GmbH‍​

* SIGNS TECHNOLOGY PARTNERSHIP AGREEMENT WITH TOYOTA MOTORSPORT GMBH‍​

UPDATE 1-Dutch firm DSM reports better-than-expected rise in Q3 profit

AMSTERDAM, Nov 2 Dutch speciality chemicals company DSM on Thursday said higher sales and tighter cost controls helped third-quarter core profit rise 13 percent, to 365 million euros ($425.3 million).

Dutch firm DSM reports better-than-expected rise in Q3 profit

AMSTERDAM, Nov 2 Dutch speciality chemicals company DSM on Thursday said higher sales and tighter cost controls helped third-quarter core profit rise 13 percent, to 365 million euros ($425.3 million).

BRIEF-Amyris Inc enters into agreement with Koninklijke DSM N.V.

* Amyris enters into product development and production agreement with Royal DSM for human nutrition ingredient

BRIEF-Amyris enters into second major product development with Royal DSM

* Amyris Inc enters into second major product development and production agreement with Royal DSM

Select another date: